previous compound ID: 2113 next compound
InChIKey: SNHRLVCMMWUAJD-SUYDQAKGSA-N
SMILES: CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "SD Macknight" "E Matthes" "R Robert" "D Rotin" "GW Carlile" "J Goepp" "DY Thomas" "B Kus" "J Liao"

chemical graph of compound 2113





CID is 16533
synonyms found at PubChem are:
BETAMETHASONE VALERATE, Betamethasone 17-valerate, 2152-44-5, Betnovate, Betaderm, Luxiq, beta-Val, Celestoderm, Bedermin, Betatrex, Bextasol, Valnac, Betnovateat, Dermovaleas, Betneval, Dermosol, Tokuderm, Betamethasone-17-valerate, Celeston valerate, beta-Methasone 17-valerate, Ecoval 70, Topagen (Veterinary), Gentocin (Veterinary), UNII-9IFA5XM7R2, 9IFA5XM7R2, C27H37FO6, CHEBI:31277, SNHRLVCMMWUAJD-SUYDQAKGSA-N, Betamethasone valerate (Betnovate), EINECS 218-439-3, [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate, Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-, 9alpha-Fluoro-16beta-methylprednisolone 17-valerate, 1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate, 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate, 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate, 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate, 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate, 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate, Flubenisolonvalerate, (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate, 9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate, Betamethasone Valerate (Betamethasone 17-Valerate), entanoate, Bettamousse, Betaval, Fuciderm, Stanoval, Betoid, Celestoderm V, Celestoderm-V, Betnesol V, Betnesol-V, Celestan V, Celestan-V, Celestane V, Rinderon V, NCGC00274064-01, Rinderon-V (TN), Luxiq (TN), Topagen (Salt/Mix), Beta-Val (TN), Betatrex (Salt/Mix), Gentocin (Salt/Mix), Chlorophytum Borivilanum, Betamethason-17-valerate, DSSTox_CID_2673, Betamethasone 17a-valerate, D03SXE, SCHEMBL7270, CHEMBL1497, DSSTox_RID_76684, DSSTox_GSID_22673, Betamethasone 17alpha-valerate, AC1L285F, DTXSID7022673, MolPort-003-933-651, Betnovate;Celestone;Betaderm;Luxiq, ZINC3882052, Betamethasone valerate (JP17/USP), Tox21_302288, MFCD00867446, s1690, AKOS015994704, KS-1198, RL02645, Betamethasone valerate [USAN:BAN:JAN], Betamethasone valerate [USAN:USP:JAN], NCGC00255185-01, AN-14218, ST075178, CAS-2152-44-5, AB2000222, LS-118456, D01357, AB01274710-01, AB01274710_02, 152M445, BRD-K34032314-001-04-1, (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate, (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate, (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p, (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate, 12772-60-0, 149665-14-5, 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate, 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #, 944728-94-3, Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)-